Investigation of Nektar Therapeutics
Are you a former employee of Nektar Therapeutics (NKTR) and own stock in the company? Robbins LLP is investigating breaches of fiduciary duty by the officers and board of directors
Are you a former employee of Nektar Therapeutics (NKTR) and own stock in the company? Robbins LLP is investigating breaches of fiduciary duty by the officers and board of directors
Northern Dynasty (NAK) Misled Shareholders About Approval of the Pebble Project At the outset of the relevant period, Northern Dynasty announced that it was submitting a permit application to
Splunk, Inc. (SPLK) Misled Shareholders About its Third Quarter 2021 Financial Results On October 21, 2020, Splunk held a call with several analysis at the Virtual Analyst & investor
Cabot Oil and Gas Corporation (COG) Failed to Fix Faulty Gas Wells and the Resulting Water Pollution Cabot has a history of polluting Pennsylvania’s water supplies, endangering citizens, and facing
Fortress Biotech, Inc. (FBIO) Misled Shareholders About the Viability of its Intravenous Tramadol Product In December 2019, Fortress Biotech’s wholly owned subsidiary, Avenue Therapeutics, Inc., submitted a New Drug
Nasdaq Acknowledges Value of Diverse Board On December 1, 2020, Nasdaq asked the U.S. Securities and Exchange Commission for permission to require that all companies listed on its U.S. stock
Fortress Biotech, Inc. (FBIO) Misled Shareholders About the Viability of its Intravenous Tramadol Product In December 2019, Fortress Biotech’s wholly owned subsidiary, Avenue Therapeutics, Inc., submitted a New Drug
Are you a former employee of Eastman Kodak Co. (KODK) and own stock in the company? Robbins LLP is investigating breaches of fiduciary duty by the officers and board of
Cabot Oil and Gas Corporation (COG) Failed to Fix Faulty Gas Wells and the Resulting Water Pollution Cabot has a history of polluting Pennsylvania’s water supplies, endangering citizens, and facing
Attorney Advertising. Past results do not guarantee a similar outcome.
5060 Shoreham Pl., Ste. 300 San Diego, CA 92122
Disclaimer | Site Map | Privacy Policy
© 2024 – Robbins LLP
Stock Watch members receive free investment monitoring and notifications.